Hyaluronidase Subcutaneous, Injection and Moxetumomab pasudotox
Determining the interaction of Hyaluronidase Subcutaneous, Injection and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Hyaluronidase, Hyaluronidase (injection)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase Subcutaneous, Injection-Moxetumomab Pasudotox-tdfk
- Hyaluronidase Subcutaneous, Injection-Moxetumomab pasudotox-tdfk Intravenous
- Hyaluronidase Subcutaneous, Injection-Moxifloxacin
- Hyaluronidase Subcutaneous, Injection-Moxifloxacin (Systemic)
- Hyaluronidase Subcutaneous, Injection-Moxifloxacin Hydrochloride
- Hyaluronidase Subcutaneous, Injection-Moxifloxacin Injection
- Moxetumomab pasudotox-Hyate:C
- Moxetumomab pasudotox-Hybrisil
- Moxetumomab pasudotox-Hycamtin
- Moxetumomab pasudotox-Hycamtin (Topotecan Capsules)
- Moxetumomab pasudotox-Hycamtin (Topotecan Injection)
- Moxetumomab pasudotox-Hycamtin Capsules